# Authors' reply: Re: Yang et al. The road to therapy for myeloid sarcoma: navigating the complexities of subclonal MAPK/ERK mutations and clonal evolution

**Authors:** Dominik Nann, Falko Fend

PMC · DOI: 10.1002/2056-4538.70064 · The Journal of Pathology: Clinical Research · 2025-11-17

## Full-text entities

- **Genes:** MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}
- **Diseases:** myeloid sarcoma (MESH:D023981)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12623258/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12623258/full.md

---
Source: https://tomesphere.com/paper/PMC12623258